Back

Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Peripheral Vascular and Cerebrovascular Disease ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

44 More presentations in this session

Presentation thumbnail
Atlas of the immune cell repertoire in human atherosclerotic plaques characterized by single cell RNA-sequencing and multi-color flow cytometry
Mr H. Horstmann (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Peripheral artery disease impairs myocardial perfusion through increasing pulse wave reflection: The Northern Shanghai Study
Doctor S. Yu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Atrial fibrillation in a cohort of patients with peripheral arterial disease. A retrospective study of a healthcare database in UK.
Mr A. Vitalis (Colchester, GB)
Abstract Slides
Presentation thumbnail
Prevalence, specialized ambulatory care and guideline-recommended therapy of peripheral vascular diseases in Germany
Mrs O. Petrikhovich (Essen, DE)
Abstract Slides
Presentation thumbnail
Clinical impact of peripheral artery disease on acute coronary syndrome
Doctor F. Fonseca Goncalves (Vila Real, PT)
Abstract Slides

Access the full session

Session thumbnail
Peripheral Vascular and Cerebrovascular Disease ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes
28 August 2020
thumbnail
Congress Presentation
Endothelial glycocalyx improvement after six months and one-year of antiretroviral therapy in treatment naive patients with human immunodeficiency virus
26 August 2022
thumbnail
Congress Presentation
First-degree relatives of type-2 diabetic patients and dysglycaemic patients have impaired endothelial function due to decreased bioavailability of nitric oxide
27 August 2021
thumbnail
Congress Presentation
Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources